Notícias09/09/2021 Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysisWe and others have previously demonstrated that the endothelium is a primary target of the severe acute respiratory syndrome coronavirus... Repositório Covid-1909/09/2021 Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort studyWhile recent literature has shown the efficacy of the SARS-CoV-2 vaccine in preventing infection, it’s impact on need for emergency... Repositório Covid-19 09/09/2021 A edição n° 66 da Revista Facto chegou. Acesse agora!A FACTO n° 66 aborda o tema inovação. Em sua Matéria Política, destaca as dificuldades estruturais do Brasil na... Acontece na ABIFINA08/09/2021 Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care SettingsThere are limited data on the effectiveness of the vaccines against symptomatic coronavirus disease 2019 (Covid-19) currently authorized in the... Repositório Covid-1908/09/2021 EFFECT OF TOCILIZUMAB IN MORTALITY AMONG PATIENTS WITH SEVERE AND CRITICAL COVID-19: EXPERIENCE IN A THIRD-LEVEL MEDICAL CENTERThe lack of effective treatment options to reduce COVID-19 associated mortality, disease progression, and the need for invasive mechanical ventilation... Repositório Covid-1908/09/2021 OMC se reúne com a indústria brasileiraABIFINA em encontro da indústria brasileira com a vice-diretora-geral da Organização Mundial do Comércio (OMC) Acontece na ABIFINA02/09/2021 Discovery of novel inhibitors of SARS-CoV-2 main proteaseCorona Virus Disease 2019 (COVID-19), referred to as ‘New Coronary Pneumonia’, is a type of acute infectious disease caused by... Repositório Covid-1901/09/2021 Are laboratory-made, COVID-19-specific monoclonal antibodies an effective treatment for COVID-19?Antibodies are made by the body as a defence against disease. However, they can also be produced in a laboratory... Repositório Covid-1901/09/2021 Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome-CoV-2 viruses through blocking virus invasion and antiinflammatory effectThe coronavirus disease 2019 has infected over 150 million people worldwide and led to over 3 million deaths. Severe acute... Repositório Covid-1901/09/2021 In-silico strategies to combat COVID-19: A comprehensive reviewThe novel coronavirus SARS-CoV-2 since its emergence at Wuhan, China in December 2019 has been creating global health turmoil despite... Repositório Covid-1901/09/2021 Chamada Pública Nº 011 /2021Farmanguinhos/Fiocruz realiza Chamada Pública Nº 011/2021 para seleção de empresas para formalização de parceria para a transferência de tecnologia... Outras Notícias30/08/2021 Utility of various inflammatory markers in predicting outcomes of hospitalized patients with COVID-19 pneumoniaThe aim of the study is to study the utility of various inflammatory markers in predicting outcomes of hospitalized patients... Repositório Covid-19
09/09/2021 Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysisWe and others have previously demonstrated that the endothelium is a primary target of the severe acute respiratory syndrome coronavirus... Repositório Covid-19
09/09/2021 Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort studyWhile recent literature has shown the efficacy of the SARS-CoV-2 vaccine in preventing infection, it’s impact on need for emergency... Repositório Covid-19
09/09/2021 A edição n° 66 da Revista Facto chegou. Acesse agora!A FACTO n° 66 aborda o tema inovação. Em sua Matéria Política, destaca as dificuldades estruturais do Brasil na... Acontece na ABIFINA
08/09/2021 Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care SettingsThere are limited data on the effectiveness of the vaccines against symptomatic coronavirus disease 2019 (Covid-19) currently authorized in the... Repositório Covid-19
08/09/2021 EFFECT OF TOCILIZUMAB IN MORTALITY AMONG PATIENTS WITH SEVERE AND CRITICAL COVID-19: EXPERIENCE IN A THIRD-LEVEL MEDICAL CENTERThe lack of effective treatment options to reduce COVID-19 associated mortality, disease progression, and the need for invasive mechanical ventilation... Repositório Covid-19
08/09/2021 OMC se reúne com a indústria brasileiraABIFINA em encontro da indústria brasileira com a vice-diretora-geral da Organização Mundial do Comércio (OMC) Acontece na ABIFINA
02/09/2021 Discovery of novel inhibitors of SARS-CoV-2 main proteaseCorona Virus Disease 2019 (COVID-19), referred to as ‘New Coronary Pneumonia’, is a type of acute infectious disease caused by... Repositório Covid-19
01/09/2021 Are laboratory-made, COVID-19-specific monoclonal antibodies an effective treatment for COVID-19?Antibodies are made by the body as a defence against disease. However, they can also be produced in a laboratory... Repositório Covid-19
01/09/2021 Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome-CoV-2 viruses through blocking virus invasion and antiinflammatory effectThe coronavirus disease 2019 has infected over 150 million people worldwide and led to over 3 million deaths. Severe acute... Repositório Covid-19
01/09/2021 In-silico strategies to combat COVID-19: A comprehensive reviewThe novel coronavirus SARS-CoV-2 since its emergence at Wuhan, China in December 2019 has been creating global health turmoil despite... Repositório Covid-19
01/09/2021 Chamada Pública Nº 011 /2021Farmanguinhos/Fiocruz realiza Chamada Pública Nº 011/2021 para seleção de empresas para formalização de parceria para a transferência de tecnologia... Outras Notícias
30/08/2021 Utility of various inflammatory markers in predicting outcomes of hospitalized patients with COVID-19 pneumoniaThe aim of the study is to study the utility of various inflammatory markers in predicting outcomes of hospitalized patients... Repositório Covid-19
